Global Transdermal Skin Patches Market Size To Exceed USD 13.90 Billion By 2035 | CAGR of 4.91%

Global Transdermal Skin Patches Market Size To Exceed USD 13.90 Billion By 2035

According to a research report published by Spherical Insights & Consulting, the Global Transdermal Skin Patches Market Size is expected to grow from USD 8.20 Billion in 2024 to USD 13.90 Billion by 2035, at a CAGR of 4.91% during the forecast period 2025-2035.

Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Transdermal Skin Patches Market Size, Share, and COVID-19 Impact Analysis, By Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Other Types), By Application (Pain Relief, Smoking Reduction & Cessation Aid, Cardiovascular Disorders, Neurological Disorders, Hormonal Therapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. "   Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/transdermal-skin-patches-market

The transdermal skin patches market is the industry of production, distribution, and sale of adhesive patches that deliver medication through skin into the bloodstream. Transdermal skin patches are a non-invasive, painless, and convenient method of drug administration, that are preferably used over oral or injectable medications. There is increased adoption of transdermal skin patches due to factors including growing emphasis on healthcare modernization and expanding awareness about non-invasive drug delivery methods. Breakthroughs in pharmaceutical R&D, increasing disposable incomes, and improved healthcare infrastructure, along with increasing government support in the healthcare sector, are several factors that are providing market growth opportunities. The growing use of transdermal skin patches in the management of chronic diseases, particularly for pain and hormone replacement therapy, is driving the market growth. On the contrary, the growing incidence of drug failure and recalls in transdermal drug delivery systems may hamper the transdermal skin patches market.

The multi-layer drug-in-adhesive segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the transdermal skin patches market is divided into single-layer drug-in-adhesive, multi-layer drug-in-adhesive, matrix, and other types. Among these, the multi-layer drug-in-adhesive segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The superior drug delivery efficiency and versatility provided by the multi-layer drug-in-adhesive transdermal skin patches are responsible for driving the market in the multi-layer drug-in-adhesive segment.

The pain relief segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the transdermal skin patches market is divided into pain relief, smoking reduction & cessation aid, cardiovascular disorders, neurological disorders, hormonal therapy, and others. Among these, the pain relief segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The increasing prevalence of chronic pain conditions and the availability of transdermal skin patches as an effective and manageable pain relief solution are driving the market in the pain relief segment.

The hospital pharmacies segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the distribution channel, the Transdermal Skin Patches market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increased accessibility of transdermal patches in the hospital pharmacies as well as growing patient traffic and trust associated with hospitals are driving the market in the hospital pharmacies segment.

North America is expected to hold the majority share of the global transdermal skin patches market during the forecast period.

North America is expected to hold the majority share of the global transdermal skin patches market during the forecast period. The region’s growing advancement in healthcare infrastructure and regulatory framework for innovative transdermal patch technologies is propelling the market growth. Further, the increased demand for transdermal skin patches as convenient treatment options for chronic diseases like diabetes, cardiovascular disorders, and chronic pain is propelling the market demand.

Asia Pacific is anticipated to grow at the fastest pace in the global transdermal skin patches market during the forecast period. The emergence of non-invasive medication delivery techniques along with the region’s rising prevalence of chronic diseases is responsible for driving the market growth. Further, an increasing healthcare spending and emergence of advanced medical treatments are propelling the market for transdermal skin patches.

Europe is expected to hold a substantial market share of the transdermal skin patches market during the projected timeframe. The growing prevalence of chronic diseases as well as adoption of non-invasive treatment options, are driving the market for transdermal skin patches. Further, the development of new formulation among pharmaceutical industries are augmenting the market growth.

Major vendors in the global transdermal skin patches market are Teva Pharmaceutical Industries Ltd, Novartis AG, Teikoku Pharma USA Inc., Viatris Inc., Johnson & Johnson, Luye Pharma Group, Purdue Pharma Manufacturing LP, Henan Lingrui Pharmaceutical Ltd, Samyang Biopharmaceuticals Corp., Hisamitsu Pharmaceutical Co., Inc., and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In September 2023, Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, announced the publication of data reinforcing that ADLARITY (donepezil transdermal system) demonstrated favorable skin tolerability and adhesion in a placebo-controlled trial with healthy volunteers.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the transdermal skin patches market based on the below-mentioned segments:

Global Transdermal Skin Patches Market, By Type

• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• Matrix
• Other Types

Global Transdermal Skin Patches Market, By Application

• Pain Relief
• Smoking Reduction & Cessation Aid
• Cardiovascular Disorders
• Neurological Disorders
• Hormonal Therapy
• Others

Global Transdermal Skin Patches Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 Global Transdermal Skin Patches Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter